Recherche
-
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
(Nature Medicine. vol. 29, n° 6, pp. 1487-1499, 2023-06-01)Article de revueLibre accès -
Axo-axonic cells in neuropsychiatric disorders: a systematic review.
(Frontiers in Cellular Neuroscience. vol. 17, 2023-06-26)Article de revueLibre accès -
Microglia modulates hippocampal synaptic transmission and sleep duration along the light/dark cycle
(Glia, 2021)Article de revueLibre accès -
Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry
(International Journal of Molecular Sciences. vol. 24, n° 11, 2023-06-02)Article de revueLibre accès -
Cannabis and exercise: Effects of Δ9-tetrahydrocannabinol on preference and motivation for wheel-running in mice
(Progress in Neuro-Psychopharmacology & Biological Psychiatry. vol. 105, 2021-03-08)Article de revueLibre accès -
NMDARs, coincidence detectors of astrocytic and neuronal activities
(International journal of molecular sciences. vol. 22, n° 14, 2021-07-06)Article de revueLibre accès -
Metabolic Messengers: endocannabinoids
(2022)Document de travail - Pré-publicationLibre accès -
Forgetting in obesity: The pregnenolone link
(2022)Document de travail - Pré-publicationLibre accès -
Carnitine palmitoyltransferase 1C negatively regulates the endocannabinoid hydrolase ABHD6 in mice, depending on nutritional status
(British Journal of Pharmacology. vol. 178, n° 7, pp. 1507-1523, 2021-04)Article de revueLibre accès -
A Baldwin interpretation of adult hippocampal neurogenesis: from functional relevance to physiopathology
(Molecular Psychiatry. vol. 27, n° 1, pp. 383-402, 2022-01)Article de revueLibre accès